Diseases of the Colon & Rectum

, Volume 43, Issue 6, pp 775–781 | Cite as

Pathologic significance of tumor progression in locally recurrent rectal cancer

Different nature from primary cancer
  • H. Onodera
  • S. Maetani
  • K. Kawamoto
  • S. Kan
  • S. Kondo
  • M. Imamura
Original Contributions


PURPOSE: It has recently been demonstrated that the tumor growth rate is a stronger determinant of survival than the extent of the growth in local recurrence of rectal cancer. We studied which factors controlled the tumor growth rate using modern immunohistochemical methods. METHODS: In 51 patients who underwent extended resection for this condition, paraffin-embedded specimens were examined for 1) tumor angiogenesis by CD31 staining and microvessel counting, 2) apoptosis by terminal deoxynucleotide transferase-mediated deoxyuridine triphosphate-biotin nick end-labeling staining, and 3) cellular proliferative activity using anti-proliferative cell nuclear antigen antibody. The results were compared with carcinoembryonic antigen doubling time and survival. RESULTS: The five-year survival rate was 20 percent. The postoperative carcinoembryonic antigen doubling time, which was the strongest predictor of survival, correlated highly with proliferative cell nuclear antigen labeling index, but did not correlate with the apoptotic index or microvessel counts. CONCLUSION: Our study shows that cancer cell proliferation rather than apoptosis or angiogenesis is a major determinant of tumor growth rate and survival in patients with locally recurrent rectal cancer.

Key words

Locally recurrent rectal cancer Survival Prognostic factor Angiogenesis Apoptosis PCNA labeling index 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McCall JL, Cox MR, Wattchow DA. Analysis of local recurrence rates after surgery alone for rectal cancer. Int J Colorectal Dis 1995;10:126–32.Google Scholar
  2. 2.
    Rullier E, Laurent C, Carles J, Saric J, Michel P, Parneix M. Local recurrence of low rectal cancer after abdominoperineal and anterior resection. Br J Surg 1997;84:525–8.Google Scholar
  3. 3.
    Romano G, Rotondano G, D'Alessandro V,et al. Pelvic recurrence following resection of rectal cancer: a multivariate predictive model. Int Surg 1997;82:67–71.Google Scholar
  4. 4.
    Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ. Abdominoperineal excision of the rectum—an endangered operation. Norman Nigro lectureship. Dis Colon Rectum 1997;40:747–51.Google Scholar
  5. 5.
    James RD, Johnson RJ, Eddelston B, Zheng GL, Jones JM. Prognostic factors in locally recurrent rectal carcinoma treated by radiotherapy. Br J Surg 1983;70:469–72.Google Scholar
  6. 6.
    Lingareddy V, Ahmad NR, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys 1997;38:785–90.Google Scholar
  7. 7.
    Farouk R, Nelson H, Gunderson LL. Aggressive multimodality treatment for locally advanced irresectable rectal cancer. Br J Surg 1997;84:741–9.Google Scholar
  8. 8.
    Goes RN, Beart RW Jr, Simons AJ, Gunderson LL, Grado G, Streeter O. Use of brachytherapy in management of locally recurrent rectal cancer. Dis Colon Rectum 1997;40:1177–9.Google Scholar
  9. 9.
    Wanebo HJ, Gaker DL, Whitehill R, Morgan RF, Constable WC. Pelvic recurrence of rectal cancer: options for curative resection. Ann Surg 1987;205:482–95.Google Scholar
  10. 10.
    Steel G Jr, Ravikumar TS, Benotti PN. New surgical treatments for recurrent colorectal cancer. Cancer 1990;65:723–30.Google Scholar
  11. 11.
    Temple WJ, Ketcham AS. Sacral resection for control of pelvic tumors. Am J Surg 1992;163:370–4.Google Scholar
  12. 12.
    Wanebo HJ, Koness RJ, Vezeridis MP, Coen SI, Wrobleski DE. Pelvic resection of recurrent rectal cancer. Ann Surg 1994;220:586–97.Google Scholar
  13. 13.
    Gagliardi G, Hawley PR, Hershman MJ, Arnott SJ. Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 1995;82:1401–5.Google Scholar
  14. 14.
    Wiggers T, de Vries MR, Veeze-Kuypers B. Surgery for local recurrence of rectal carcinoma. Dis Colon Rectum 1996;39:323–8.Google Scholar
  15. 15.
    Hoffman JP, Riley L, Carp NZ, Litwin S. Isolated locally recurrent rectal cancer: a review of incidence, presentation, and management. Semin Oncol 1993;20:506–19.Google Scholar
  16. 16.
    Schneebaum S, Arnold MW, Young D,et al. Role of carcinoembryonic antigen in predicting resectability of recurrent colorectal cancer. Dis Colon Rectum 1993;36:810–5.Google Scholar
  17. 17.
    Maetani S, Nishikawa T, Iijima Y,et al. Extensiveen bloc resection of regionally recurrent carcinoma of the rectum. Cancer 1992;69:2876–83.Google Scholar
  18. 18.
    Maetani S, Onodera H, Nishikawa T,et al. The significance of local recurrence of rectal cancer as a local or disseminated disease. Br J Surg 1998;85:521–5.Google Scholar
  19. 19.
    Folkman J. Angiogenesis and angiogenesis inhibitor: an overview. EXS 1997;79:1–8.Google Scholar
  20. 20.
    O'Reilly MS, Boehm T, Shing Y,et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277–85.Google Scholar
  21. 21.
    Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994;73:2013–26.Google Scholar
  22. 22.
    Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957–67.Google Scholar
  23. 23.
    Welin S, Youker J, Spratt JS Jr. The rates and patterns of the large intestine and rectum observed serially by double-contrast enema study (Malmo technique). Am J Roentgenol Radium Ther Nucl Med 1963;90:673–87.Google Scholar
  24. 24.
    Bolin S, Nilsson E, Sjödahl R. Carcinoma of the colon and rectum—growth rate. Ann Surg 1983;198:151–8.Google Scholar
  25. 25.
    Staah HJ, Anderer FA, Stumph E, Fisher R. Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. 1978;136:324–7.Google Scholar
  26. 26.
    Bosari S, Lee AK, Dellellis RA, Wiley BD, Heatley GJ, Silverman ML. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 1992;23:755–61.Google Scholar
  27. 27.
    Bozzetti F, Bertario L. Rossetti C,et al. Surgical treatment of locally recurrent rectal cancer. Dis Colon Rectum 1997;40:1421–4.Google Scholar
  28. 28.
    Ogunbiyi OA, McKenna K, Birnbaum EH, Fleshman JW, Kodner IJ. Aggressive surgical management of recurrent rectal cancer—is it worthwhile? Dis Colon Rectum 1997;40:150–5.Google Scholar
  29. 29.
    Suzuki K, Dorozois RR, Devine RM, Nelson H, Weaver AL, Gunderson LL. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum. 1996;39:730–6.Google Scholar
  30. 30.
    Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg 1996;83:293–304.Google Scholar
  31. 31.
    Scholefield JH, Northover JMA. Surgical management of rectal cancer. Br J Surg 1995;82:745–8.Google Scholar
  32. 32.
    Lindmark G, Gerdin B, Sundberg C, Påhlman L, Bergstrom R, Glimelius B. Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol 1996;14:461–6.Google Scholar
  33. 33.
    Engel CJ, Bennett ST, Chambers AF, Doig GS, Kerkvliet N, O'Malley FP. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol 1996;20:1260–5.Google Scholar
  34. 34.
    Frank RE, Sacclarides TJ, Leurgans S, Speziale NJ, Drab EA, Rubin DB. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 1995;222:695–9.Google Scholar
  35. 35.
    Tanigawa N, Amaya H, Matumura M, Lu C, Kitaoka A, Matuyama K, Muraoka R. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 1997;57:1043–6.Google Scholar
  36. 36.
    Bossi P, Viale G, Lee AK, Alfano R, Coggi G, Bosari S. Angiogenesis in colorectal tumors: microvessel quantitation in adenoma and carcinoma with clinicopathological correlations. Cancer Res 1995;55:5049–53.Google Scholar
  37. 37.
    Langlois NE, Lamb J, Eremin O, Heys SD. Apoptosis in colorectal cancer occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products. J Pathol 1997;182:392–7.Google Scholar
  38. 38.
    Graeber TG, Osmanian C, Jacks T,et al. Hypoxiamediated selection of cells with diminished apoptotic potential in solid tumors. Nature 1996;379:88–91.Google Scholar
  39. 39.
    Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating cell antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993;71:2454–60.Google Scholar
  40. 40.
    Liao G, Zhang Y, Shen M, Jiang H, Yan Z. Significance of proliferating cell nuclear antigen expression in liver metastasis of colorectal cancer. Dis Colon Rectum 1997;40:1489–93.Google Scholar
  41. 41.
    Al-Sheneber IF, Shibata HR, Sampalis J, Jothy S. Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 1993;71:1954–9.Google Scholar
  42. 42.
    Neoptolemos JP, Oates GD, Newbold KM, Robson AM, McConkey C, Powell J. Cyclin/proliferative cell nuclear immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classification for colorectal cancer. Br J Surg 1995;82:184–7.Google Scholar
  43. 43.
    Kawamoto K, Onodera H, Kondo S,et al. Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival. Oncology 1998;55:242–8.Google Scholar

Copyright information

© The American Society of Colon and Rectal Surgeons 2000

Authors and Affiliations

  • H. Onodera
    • 2
  • S. Maetani
    • 1
  • K. Kawamoto
    • 2
  • S. Kan
    • 2
  • S. Kondo
    • 2
  • M. Imamura
    • 2
  1. 1.the Tenri Institute of Medical ResearchTenriJapan
  2. 2.Department of Surgery and Surgical Basic Science, Faculty of MedicineKyoto UniversityKyotoJapan

Personalised recommendations